drugset / Trial / NCT00902668
Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer
NaSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Drugs, such as lovastatin, may protect normal cells from the side effects of radiation therapy. PURPOSE: This phase II trial is studying how well lovastatin works in reducing side effects after radiation therapy in women with breast cancer.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | — | Oral |